Inventor · disambiguated record
Petra Rietschel
Also filed as: RIETSCHEL PETRA
2 granted patents·3 pending applications·8 citations·filing 2018–2024
56Inventor score
Files withREGENERON PHARMA5
Top patents by PatentIndex Score
5 records- 0191US11926668B2Anti-PD-1 antibodies for treatment of lung cancerREGENERON PHARMA·Filed 2022·Granted Mar 12, 2024·3 cites·30 claims
- 0284US11292842B2Anti-PD-1 antibodies for treatment of lung cancerREGENERON PHARMA·Filed 2018·Granted Apr 5, 2022·5 cites·29 claims
- 0373US2024209090A1Anti-pd-1 antibodies for treatment of lung cancerREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0456US2024084041A1Methods of treating non-small cell lung cancer using mesenchymal epithelial transition factor (met)-targeted agentsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0556US2025270321A1Methods of treating lung cancer by administering a pd-1 inhibitorREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Petra Rietschel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →